In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capivasertib (trade name: Truqap) is the world’s first approved AKT protein kina···【more】
Release date:2026-01-13Recommended:27
Capivasertib in combination with fulvestrant can be used as a second-line or thi···【more】
Release date:2026-01-13Recommended:31
Capivasertib in combination with Faslodex is indicated for the treatment of adul···【more】
Release date:2026-01-13Recommended:32
Capivasertib, in combination with Fulvestrant, is indicated for the treatment of···【more】
Release date:2026-01-13Recommended:28
Capivasertib belongs to a class of medications known as antineoplastic agents. I···【more】
Release date:2026-01-13Recommended:36
On November 17, 2023, AstraZeneca’s capivasertib in combination with Faslodex (f···【more】
Release date:2026-01-13Recommended:32
On June 12, 2023, the New Drug Application (NDA) for capivasertib in combination···【more】
Release date:2026-01-13Recommended:31
Capmatinib slows down or inhibits the spread of cancer cells by blocking a key p···【more】
Release date:2026-01-09Recommended:33
The mechanism of action of capmatinib lies in targeting and blocking the specifi···【more】
Release date:2026-01-09Recommended:30
Camatinib is indicated for the treatment of specific types of non-small cell lun···【more】
Release date:2026-01-09Recommended:30
During treatment with capmatinib, your doctor will need to regularly monitor you···【more】
Release date:2026-01-09Recommended:26
Capmatinib may make your skin more sensitive to sunlight, sunlamps, and tanning ···【more】
Release date:2026-01-09Recommended:29